For: | Leung PY, Chen W, Sari AN, Sitaram P, Wu PK, Tsai S, Park JI. Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival. World J Gastroenterol 2024; 30(7): 714-727 [PMID: 38515951 DOI: 10.3748/wjg.v30.i7.714] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i7/714.htm |
Number | Citing Articles |
1 |
Ashwani Sharma, Tarun Virmani, Girish Kumar, Anjali Sharma, Reshu Virmani, Dalapathi Gugulothu, Kuldeep Singh, Shashi Kiran Misra, Kamla Pathak, Nitin Chitranshi, Henrique Douglas Melo Coutinho, Divya Jain. Mitochondrial signaling pathways and their role in cancer drug resistance. Cellular Signalling 2024; 122: 111329 doi: 10.1016/j.cellsig.2024.111329
|
2 |
Akhmed Aslam, Faisal Minshawi, Hussain Almasmoum, Riyad Almaimani, Aiman Alsaegh, Amani A. Mahbub, Mohammad S. Iqbal, Aisha Tabassum, Mohamed E. Elzubier, Shakir Idris, Wesam F. Farrash, Bassem Refaat. Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation. Journal of the Egyptian National Cancer Institute 2025; 37(1) doi: 10.1186/s43046-025-00261-7
|
3 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|